BVF as of Dec. 31, 2011
Portfolio Holdings for BVF
BVF holds 20 positions in its portfolio as reported in the December 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rigel Pharmaceuticals | 18.9 | $55M | 7.0M | 7.89 | |
| Neurocrine Biosciences (NBIX) | 17.3 | $50M | 5.9M | 8.50 | |
| Nektar Therapeutics | 14.7 | $43M | 7.6M | 5.59 | |
| Ligand Pharmaceuticals In (LGND) | 14.2 | $41M | 3.5M | 11.87 | |
| Infinity Pharmaceuticals (INFIQ) | 6.6 | $19M | 2.2M | 8.84 | |
| Targacept | 6.3 | $18M | 3.3M | 5.57 | |
| Array BioPharma | 6.1 | $18M | 8.2M | 2.16 | |
| ISIS Pharmaceuticals | 4.8 | $14M | 1.9M | 7.21 | |
| Flamel Technologies | 3.5 | $10M | 2.0M | 5.21 | |
| Oncothyreon | 1.9 | $5.7M | 748k | 7.58 | |
| Myrexis (MYRX) | 1.2 | $3.6M | 1.3M | 2.68 | |
| A.P. Pharma (APPA) | 1.1 | $3.1M | 13M | 0.23 | |
| Genvec | 1.0 | $2.8M | 1.2M | 2.33 | |
| Palatin Technologies | 0.7 | $2.1M | 5.2M | 0.40 | |
| Capstone Therapeutics | 0.7 | $2.0M | 7.8M | 0.26 | |
| Ironwood Pharmaceuticals (IRWD) | 0.4 | $1.0M | 87k | 11.97 | |
| NeurogesX | 0.3 | $1.0M | 1.2M | 0.85 | |
| Cadus Corporation | 0.1 | $364k | 269k | 1.35 | |
| Osteologix (OLGX) | 0.1 | $294k | 1.6M | 0.18 | |
| AutoImmune (AIMM) | 0.0 | $0 | 3.6M | 0.00 |
